Open AccessBreakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
Author(s) -
Georgios Tsironis,
Dimitrios C. Ziogas,
Anastasios Kyriazoglou,
Marita Lykka,
Konstantinos Koutsoukos,
Aristotelis Bamias,
Meletios Α. Dimopoulos
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.02.18
Subject(s) - ramucirumab , medicine , erlotinib , nivolumab , oncology , atezolizumab , pembrolizumab , durvalumab , afatinib , lung cancer , epidermal growth factor receptor , cancer research , chemotherapy , immunotherapy , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom